Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1960 Jan 9;1(5166):78–90. doi: 10.1136/bmj.1.5166.78

Clinical and Metabolic Studies in Thyroid Disease—II*

E J Wayne
PMCID: PMC1966196  PMID: 13843211

Full text

PDF
78

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AIKAWA J. K., HARRELL G. T., EISENBERG B. The exchangeable potassium content of normal women. J Clin Invest. 1952 Apr;31(4):367–369. doi: 10.1172/JCI102617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ANDERSON J. R., GOUDIE R. B., GRAY K. G. The thyrotoxic complement-fixation reaction. Scott Med J. 1959 Feb;4(2):64–74. doi: 10.1177/003693305900400202. [DOI] [PubMed] [Google Scholar]
  3. AXELROD A. R., BERMAN L. The bone marrow in hyperthyroidism and hypothyroidism. Blood. 1951 May;6(5):436–453. [PubMed] [Google Scholar]
  4. BARTELS E. C. Post-thyroidectomy myxedema after preoperative use of antithyroid drugs. J Clin Endocrinol Metab. 1953 Jan;13(1):95–106. doi: 10.1210/jcem-13-1-95. [DOI] [PubMed] [Google Scholar]
  5. BAUER R. E. The present status of the diagnosis of hyperthyroidism. Ann Intern Med. 1956 Jan;44(1):207–214. doi: 10.7326/0003-4819-44-1-207. [DOI] [PubMed] [Google Scholar]
  6. BERNSTEIN L. M., HICK F. K., INOUYE T., JOHNSTON L. C., RYAN R. Body composition as related to heat regulation in women. J Appl Physiol. 1956 Sep;9(2):241–256. doi: 10.1152/jappl.1956.9.2.241. [DOI] [PubMed] [Google Scholar]
  7. BERSON S. A., YALOW R. S., SORRENTINO J., ROSWIT B. The determination of thyroidal and renal plasma I131 clearance rates as a routine diagnostic test of thyroid dysfunction. J Clin Invest. 1952 Feb;31(2):141–158. doi: 10.1172/JCI102585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. BLOMFIELD G. W., ECKERT H., FISHER M., MILLER H., MUNRO D. S., WILSON G. M. Treatment of thyrotoxicosis with 131 I; a review of 500 cases. Br Med J. 1959 Jan 10;1(5114):63–74. doi: 10.1136/bmj.1.5114.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BLOMFIELD G. W., JONES J. C., MILLER H., MACGREGOR A. G., WAYNE E. J., WEETCH R. S. Treatment of thyrotoxicosis with radioactive iodine; review of 140 cases. Br Med J. 1955 Nov 19;2(4950):1223–1229. doi: 10.1136/bmj.2.4950.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BUCHANAN J., BUCHANAN W. W., CROOKS J., GALE G. E. The use of reserpine in the treatment of thyrotoxicosis. Scott Med J. 1959 Oct;4:486–490. doi: 10.1177/003693305900401004. [DOI] [PubMed] [Google Scholar]
  11. BUCHANAN W. W., ANDERSON J. R., GOUDIE R. B., GRAY K. G. A skin test in thyroid disease. Lancet. 1958 Nov 1;2(7053):928–931. [PubMed] [Google Scholar]
  12. CANARY J. J., SCHAAF M., DUFFY B. J., Jr, KYLE L. H. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med. 1957 Sep 5;257(10):435–442. doi: 10.1056/NEJM195709052571001. [DOI] [PubMed] [Google Scholar]
  13. COENEGRACHT J., FRASER R. Measurement of the early thyroid clearance of radioiodine as a clinical test. J Endocrinol. 1955 May;12(3):185–195. doi: 10.1677/joe.0.0120185. [DOI] [PubMed] [Google Scholar]
  14. CORSA L., Jr, OLNEY J. M., Jr, STEENBURG R. W., BALL M. R., MOORE F. D. The measurement of exchangeable potassium in man by isotope dilution. J Clin Invest. 1950 Oct;29(10):1280–1295. doi: 10.1172/JCI102365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. CROOKS J., BLUHM M. M., MULDOWNEY F. P. The interrelation between total exchangeable sodium, potassium and chloride, and lean body mass in man. Clin Sci. 1959 May;18:175–184. [PubMed] [Google Scholar]
  16. CROOKS J., MURRAY I. P., WAYNE E. J. Basal metabolic rate in thyrotoxicosis. Lancet. 1958 Mar 22;1(7021):604–607. doi: 10.1016/s0140-6736(58)90865-1. [DOI] [PubMed] [Google Scholar]
  17. DANOWSKI T. S., ELKINTON J. R. Exchanges of potassium related to organs and systems. Pharmacol Rev. 1951 Mar;3(1):42–58. [PubMed] [Google Scholar]
  18. FARRAN H. E. The immediate uptake of radioactive iodine as a test of thyroid function. Br Med J. 1958 Nov 1;2(5104):1060–1062. doi: 10.1136/bmj.2.5104.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. FLETCHER C. M. The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med. 1952 Sep;45(9):577–584. [PubMed] [Google Scholar]
  20. FOLLIS R. H., Jr Skeletal changes associated with hyperthyroidism. Bull Johns Hopkins Hosp. 1953 Jun;92(6):405–421. [PubMed] [Google Scholar]
  21. FOLLIS R. H., Jr Skeletal changes associated with hyperthyroidism. Bull Johns Hopkins Hosp. 1953 Jun;92(6):405–421. [PubMed] [Google Scholar]
  22. FORBES G. B., LEWIS A. M. Total sodium, potassium and chloride in adult man. J Clin Invest. 1956 Jun;35(6):596–600. doi: 10.1172/JCI103313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. FRANCOIS P. E., GOLDBERG I. J., GOOLDEN A. W., McKINNEL A., MALLARD J. R. Variations in thyroid function in normal subjects. Clin Sci. 1958 Aug;17(3):545–553. [PubMed] [Google Scholar]
  24. FRASER R. Clinical tests of thyroid function. Lancet. 1956 Sep 22;271(6943):581–586. doi: 10.1016/s0140-6736(56)92289-9. [DOI] [PubMed] [Google Scholar]
  25. GABRILOVE J. L., LUDWIG A. W. The histogenesis of myxedema. J Clin Endocrinol Metab. 1957 Aug;17(8):925–932. doi: 10.1210/jcem-17-8-925. [DOI] [PubMed] [Google Scholar]
  26. GODLEY A. F., STANBURY J. B. Preliminary experience in the treatment of hyperthyroidism with potassium perchlorate. J Clin Endocrinol Metab. 1954 Jan;14(1):70–78. doi: 10.1210/jcem-14-1-70. [DOI] [PubMed] [Google Scholar]
  27. GOODWIN J. F., MACGREGOR A. G., MILLER H., WAYNE E. J. The use of radioactive iodine in the assessment of thyroid function. Q J Med. 1951 Oct;20(80):353–387. [PubMed] [Google Scholar]
  28. GOOLDEN A. W., MALLARD J. R. The use of iodine 132 in studies of thyroid function. Br J Radiol. 1958 Nov;31(371):589–595. doi: 10.1259/0007-1285-31-371-589. [DOI] [PubMed] [Google Scholar]
  29. GOUDIE R. B., ANDERSON J. R., GRAY K. G. Complement-fixing antithyroid antibodies in hospital patients with asymptomatic thyroid lesions. J Pathol Bacteriol. 1959 Apr;77(2):389–400. doi: 10.1002/path.1700770208. [DOI] [PubMed] [Google Scholar]
  30. GROSS J., PITT-RIVERS R. Physiological activity of 3:5:3'-L-triiodothyronine. Lancet. 1952 Mar 22;1(6708):593–594. doi: 10.1016/s0140-6736(52)90104-9. [DOI] [PubMed] [Google Scholar]
  31. Gibson J. G., Harris A. W. CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. J Clin Invest. 1939 Jan;18(1):59–65. doi: 10.1172/JCI101026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. HALNAN K. E., POCHIN E. E. The use of iodine 132 for thyroid function tests. Br J Radiol. 1958 Nov;31(371):581–588. doi: 10.1259/0007-1285-31-371-581. [DOI] [PubMed] [Google Scholar]
  33. HANBURY E. M., Jr, HESLIN J., STANG L. G., Jr, TUCKER W. D., RALL J. E. The diagnostic use of I132. J Clin Endocrinol Metab. 1954 Dec;14(12):1530–1538. doi: 10.1210/jcem-14-12-1530. [DOI] [PubMed] [Google Scholar]
  34. HARINGTON C. R., PITT-RIVERS R. Note on the synthesis of the acetic acid analogue of thyroxine. Biochem J. 1952 Feb;50(4):438–439. doi: 10.1042/bj0500438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. HOWARTH A. E., LLOYD H. E. Perceptive deafness in hypothyroidism. Br Med J. 1956 Feb 25;1(4964):431–433. doi: 10.1136/bmj.1.4964.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. HUBBLE D. The diagnosis and treatment of auto-immunising thyroiditis. Scott Med J. 1959 Feb;4(2):55–63. doi: 10.1177/003693305900400201. [DOI] [PubMed] [Google Scholar]
  37. Harington C. R., Barger G. Chemistry of Thyroxine: Constitution and Synthesis of Thyroxine. Biochem J. 1927;21(1):169–183. doi: 10.1042/bj0210169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Harington C. R. Chemistry of Thyroxine: Isolation of Thyroxine from the Thyroid Gland. Biochem J. 1926;20(2):293–299. doi: 10.1042/bj0200293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hart F. D., Maclagan N. F. Oral Thyroxine in the Treatment of Myxoedema. Br Med J. 1950 Mar 4;1(4652):512–518. doi: 10.1136/bmj.1.4652.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. IKKOS D., LJUNGGREN H., LUFT R., SJOGREN B. Content and distribution of potassium and chloride in adults. Metabolism. 1955 May;4(3):231–237. [PubMed] [Google Scholar]
  41. IKKOS D., LJUNGGREN H., LUFT R. The relation between extracellular and intracellular water in acromegaly. Acta Endocrinol (Copenh) 1956 Mar;21(3):211–225. doi: 10.1530/acta.0.0210211. [DOI] [PubMed] [Google Scholar]
  42. INGBAR S. H., FREINKEL N. Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease. J Clin Invest. 1958 Nov;37(11):1603–1614. doi: 10.1172/JCI103753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. KLEEMAN C. R., TUTTLE S., BASSETT S. H. Metabolic observations in a case of thyrotoxicosis with hypercalcemia. J Clin Endocrinol Metab. 1958 May;18(5):477–491. doi: 10.1210/jcem-18-5-477. [DOI] [PubMed] [Google Scholar]
  44. KRANE S. M., BROWNELL G. L., STANBURY J. B., CORRIGAN H. The effect of thyroid disease on calcium metabolism in man. J Clin Invest. 1956 Aug;35(8):874–887. doi: 10.1172/JCI103340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. KURLAND G. S., HAMOLSKY M. W., FREEDBERG A. S. Studies in non-myxedematous hypometabolism. I. The clinical syndrome and the effects of thiiodothyronine, alone or combined with thyroxine. J Clin Endocrinol Metab. 1955 Nov;15(11):1354–1360. doi: 10.1210/jcem-15-11-1354. [DOI] [PubMed] [Google Scholar]
  46. MACGREGOR A. G. Simplified radioactive iodine therapy. Br Med J. 1957 Mar 2;1(5017):492–495. doi: 10.1136/bmj.1.5017.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. MONCKE C. L. Hyperthyreosebehandlung mit Reserpin. Medizinische. 1955 Dec 10;(50):1742–1744. [PubMed] [Google Scholar]
  48. MOORE F. D., HALEY H. B., BERING E. A., Jr, BROOKS L., EDELMAN I. S. Further observations on total body water. II. Changes of body composition in disease. Surg Gynecol Obstet. 1952 Aug;95(2):155–180. [PubMed] [Google Scholar]
  49. MORGANS M. E., TROTTER W. R. Treatment of thyrotoxicosis with potassium perchlorate. Lancet. 1954 Apr 10;266(6815):749–751. doi: 10.1016/s0140-6736(54)92714-2. [DOI] [PubMed] [Google Scholar]
  50. MULDOWNEY F. P., CROOKS J., WAYNE E. J. The total red cell mass in thyrotoxicosis and myxoedema. Clin Sci. 1957 May;16(2):309–314. [PubMed] [Google Scholar]
  51. MULDOWNEY F. P. The relationship of total red cell mass to lean body mass in man. Clin Sci. 1957 Feb;16(1):163–169. [PubMed] [Google Scholar]
  52. MUNRO D. S., RENSCHLER H., WILSON G. M. Exchangeable potassium and sodium in hyperthyroidism and hypothyroidism. Metabolism. 1958 Mar;7(2):124–132. [PubMed] [Google Scholar]
  53. MURRAY I. P., SIMPSON J. A. [Acroparaesthesia in myxoedema; a clinical and electromyographic study]. Lancet. 1958 Jun 28;1(7035):1360–1363. doi: 10.1016/s0140-6736(58)92166-4. [DOI] [PubMed] [Google Scholar]
  54. McGIRR E. M., HUTCHISON J. H., CLEMENT W. E. Sporadic goitre due to dyshormonogenesis: impaired utilization of trapped iodide. Scott Med J. 1959 Mar;4(3):107–114. doi: 10.1177/003693305900400301. [DOI] [PubMed] [Google Scholar]
  55. NORDIN B. E. Assessment of calcium excretion from the urinary calcium/creatinine ratio. Lancet. 1959 Sep 19;2(7099):368–371. doi: 10.1016/s0140-6736(59)91635-6. [DOI] [PubMed] [Google Scholar]
  56. OWEN S. G., SMART G. A. Thyroid antibodies in myxoedema. Lancet. 1958 Nov 15;2(7055):1034–1036. doi: 10.1016/s0140-6736(58)90531-2. [DOI] [PubMed] [Google Scholar]
  57. PITT-RIVERS R. Physiological activity of the acetic-acid analogues of some iodinated thyronines. Lancet. 1953 Aug 1;265(6779):234–235. doi: 10.1016/s0140-6736(53)90164-0. [DOI] [PubMed] [Google Scholar]
  60. RAPPORT R. L., CURTIS G. M. The clinical significance of the blood iodine; a review. J Clin Endocrinol Metab. 1950 Jul;10(7):735–790. doi: 10.1210/jcem-10-7-735. [DOI] [PubMed] [Google Scholar]
  61. RIGGS D. S. Quantitative aspects of iodine metabolism in man. Pharmacol Rev. 1952 Sep;4(3):284–370. [PubMed] [Google Scholar]
  62. ROITT I. M., DONIACH D., CAMPBELL P. N., HUDSON R. V. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956 Oct 20;271(6947):820–821. doi: 10.1016/s0140-6736(56)92249-8. [DOI] [PubMed] [Google Scholar]
  63. ROITT I. M., DONIACH D. Human autoimmune thyroiditis: serological studies. Lancet. 1958 Nov 15;2(7055):1027–1033. doi: 10.1016/s0140-6736(58)90530-0. [DOI] [PubMed] [Google Scholar]
  64. SCHULTZ A. L., ZIEVE L. Alterations in thyroid I-131 uptake, basal metabolic rate and serum cholesterol following treatment of hyperthyroidism with radioactive iodine; value in early prediction of success or failure of therapy. Am J Med. 1956 Jan;20(1):30–41. doi: 10.1016/0002-9343(56)90170-x. [DOI] [PubMed] [Google Scholar]
  65. TITTLE C. R. Effects of 3,5,3' l-triiodothyronine in patients with metabolic insufficiency; preliminary report. J Am Med Assoc. 1956 Sep 22;162(4):271–274. doi: 10.1001/jama.1956.02970210011005. [DOI] [PubMed] [Google Scholar]
  66. WILLIAMS R. H., TOWERY B. T. Radioiodotherapeusis. Am J Med. 1949 Dec;7(6):702-17, illust. doi: 10.1016/0002-9343(49)90409-x. [DOI] [PubMed] [Google Scholar]
  67. WILSON G. M., KILPATRICK R., ECKERT H., CURRAN R. C., JEPSON R. P., BLOMFIELD G. W., MILLER H. Thyroid neoplasms following irradiation. Br Med J. 1958 Oct 18;2(5102):929–934. doi: 10.1136/bmj.2.5102.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. ZIEVE L., VOGEL W. C., SCHULTZ A. L. Determination of protein-bound radioiodine with an anion exchange resin. J Lab Clin Med. 1956 Apr;47(4):663–668. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES